Advancing the treatment for cancer patients in Morocco, Clinique d’Oncologie 16 Novembre has acquired and installed the Ethos™ therapy system – the first of its kind in Africa – from Varian, a Siemens Healthineers company. Ethos therapy, which is uniquely powered by artificial intelligence (AI), provides cancer patients with a personalized, adaptive radiotherapy treatment within a typical 15 to 30-minute time slot.
Adaptive therapy customizes the patient’s treatment based on tumor and anatomical changes that occur over a multi-week course of treatment. The goal is to better target the tumor, reduce doses to healthy tissue, and improve overall outcomes.
“We are proud to be the first cancer center in Africa to offer Ethos therapy treatment,” said Dr. Mounir Bachouchi, medical oncologist and CEO at Clinique d’Oncologie 16 Novembre. “Adaptive therapy has so many benefits for both the patient and the clinician, and Varian’s Ethos system is at the leading edge of this technology, enabling our clinical team to adapt every treatment to changes in a patient’s anatomy from day to day, potentially improving overall outcomes.”
“Every patient deserves access to the best and most personalized cancer care,” said José-Manuel Valentim, Director of Africa operations at Varian. “Clinique d’Oncologie 16 Novembre is a very forward-thinking cancer center focused on offering state-of-the-art cancer care with the most advanced technologies available.”
By providing an up-to-date view of the patient’s anatomy—and the ability to use that information to adapt the treatment— Ethos therapy provides clinicians the confidence to make more informed treatment decisions. The solution is built on Varian’s latest treatment delivery technology and provides fast imaging and treatment delivery without compromising quality.
“Adaptive therapy is the future of personalized radiation therapy, and we are excited that this center is taking on a leadership role by offering Ethos to the cancer patients of Morocco,” added Valentim. “This is a transformational moment for cancer care in Northern Africa.”